In Silico Discovery of JMJD6 Inhibitors for Cancer Treatment.
Sign Up to like & getrecommendations! Published in 2019 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.9b00264
Abstract: The 2-oxoglutarate (2OG)-dependent oxygenase JMJD6 is emerging as a potential anticancer target, but its inhibitors have not been reported so far. In this study, we reported an in silico protocol to discover JMJD6 inhibitors targeting… read more here.
Keywords: jmjd6; jmjd6 inhibitors; discovery jmjd6; silico discovery ... See more keywords